DDReg Pharma provides specialized Regulatory Services in USA for the US market, assisting life sciences companies with ANDA, NDA, and 505(b)(2) submissions. Their expertise includes managing US FDA queries (Prescribing Information and CMC), eCTD publishing, and pharmacovigilance (US Agent representation). In 2026, they have focused heavily on AI-driven submission planning and navigating the FDA’s new shifts in biosimilar development and digital oversight.
Looking for expert regulatory affairs services in Canada? Our experienced team p...
Drug Shortages & Regulatory Affairs: A Silent Compliance Challenge
New Zealand currently regulates medical devices under the Medicines Act 1981. Al...
Process validation is set to shift again by 2026 as agencies push for clearer pr...
Discover how DDReg's VITALIC® platform, a comprehensive Regulatory Information M...
Discover how DDReg's RegIntel platform leverages AI and real-time data to provid...
Regulatory Services in USA : DDReg Pharma
Regulatory Services in UK : DDReg Pharma